LEVOFLOXACIN KABI

Main information

  • Trade name:
  • LEVOFLOXACIN KABI Solution for infusion 5MG/ML
  • Dosage:
  • 5MG/ML
  • Pharmaceutical form:
  • Solution for infusion
  • Administration route:
  • Intravenous use
  • Units in package:
  • 10X50ML Bottle
  • Prescription type:
  • with prescription
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • LEVOFLOXACIN KABI Solution for infusion 5MG/ML
    Czech Republic
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • LEVOFLOXACIN
  • Product summary:
  • LEVOFLOXACIN KABI

Other information

Status

  • Source:
  • SUKL - Státní ústav pro kontrolu léčiv
  • Authorization status:
  • R - active MA/authorised medicinal product
  • Authorization number:
  • 42/ 117/13-C
  • EAN code:
  • 8595173621159
  • Last update:
  • 17-01-2018

11-6-2018

Quinsair (Chiesi Farmaceutici S.p.A.)

Quinsair (Chiesi Farmaceutici S.p.A.)

Quinsair (Active substance: levofloxacin) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)3756 of Mon, 11 Jun 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/2789/T/16

Europe -DG Health and Food Safety